Diseases, Conditions, Syndromes

Sofosbuvir plus ledipasvir seems effective for HCV genotype 1

(HealthDay)—For patients with chronic hepatitis C virus genotype 1 (HCV GT-1) infection who are ineligible for interferon therapy, and who relapsed after sofosbuvir and ribavirin treatment, sofosbuvir plus ledipasvir is ...

Diseases, Conditions, Syndromes

Predicting hepatitis C treatment success

Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers at Kanazawa University suggest.

Diseases, Conditions, Syndromes

Doctor details two new hepatitis C drugs

In the last three weeks, the Food and Drug Administration has approved two new drugs that are expected to dramatically improve treatment of chronic hepatitis C, a liver-damaging viral infection that afflicts more than 3.2 ...

page 2 from 4